Bath & Body Works officer awarded 40,921 RSUs

Bath & Body Works, Inc. Chief Supply Chain Officer Thomas E. Mazurek reported routine equity compensation activity.

Rhea-AI Filing Summary

Bath & Body Works, Inc. Chief Supply Chain Officer Thomas E. Mazurek reported routine equity compensation activity. On March 12, 2026, he received a grant of 40,921 restricted stock units that vest 30% on the first and second anniversaries of the grant date and 40% on the third anniversary. On March 13, 2026, 6,327 shares of common stock at $19.50 per share were withheld to cover tax obligations related to RSU vesting, not sold on the open market. Following these transactions, he directly holds 112,681.404 shares of common stock, including shares acquired through the company’s dividend reinvestment plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Mazurek Thomas E.

Role Chief Supply Chain Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, $0.50 par value	6,327	$19.50	$123K
Grant/Award	Common Stock, $0.50 par value	40,921	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.50 par value — 112,681.404 shares (Direct)

Footnotes (3)

1. F1. Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date.
2. F2. Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations.
3. F3. Total includes 354.827 shares acquired pursuant to the Issuer's Dividend Reinvestment Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BBWI’s Thomas E. Mazurek report on this Form 4?

Thomas E. Mazurek reported two transactions: a grant of 40,921 restricted stock units on March 12, 2026, and a disposition of 6,327 shares on March 13, 2026, withheld solely to cover tax obligations on vested RSUs, not an open-market sale.

How many Bath & Body Works (BBWI) shares does Thomas E. Mazurek hold after these transactions?

After the reported grant and tax withholding, Thomas E. Mazurek directly holds 112,681.404 shares of Bath & Body Works common stock. This total includes 354.827 shares acquired through the company’s Dividend Reinvestment Plan, as noted in the Form 4 footnotes.

What are the vesting terms of the 40,921 RSUs granted to BBWI’s Chief Supply Chain Officer?

The 40,921 restricted stock units vest over three years: 30% on the first anniversary of the March 12, 2026 grant date, another 30% on the second anniversary, and the remaining 40% on the third anniversary, aligning vesting with longer-term service and retention.

Was the 6,327-share disposition by BBWI’s Thomas E. Mazurek an open-market sale?

No. The 6,327 shares reported as a disposition were withheld by Bath & Body Works to satisfy tax withholding obligations arising from restricted stock unit vesting. The Form 4 notes this as a tax-withholding event, not a discretionary open-market sale.

What type of security is involved in Thomas E. Mazurek’s BBWI Form 4 filing?

The Form 4 covers Bath & Body Works common stock with a $0.50 par value and related restricted stock units. One transaction reflects an RSU grant, while the other reflects shares withheld in connection with RSU vesting and related tax obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 06:24 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mazurek Thomas E.

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OH 43230

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Supply Chain Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	03/12/2026		A		40,921(1)	A	$0.0000	118,653.577	D
Common Stock, $0.50 par value	03/13/2026		F		6,327(2)	D	$19.5	112,681.404(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units vesting 30% on the first anniversary of March 12, 2026 (the "Grant Date"), 30% on the second anniversary of the Grant Date and 40% on the third anniversary of the Grant Date.

2. Represents shares withheld in connection with the vesting of restricted stock units to cover tax withholding obligations.

3. Total includes 354.827 shares acquired pursuant to the Issuer's Dividend Reinvestment Plan.

	Robert J. Tannous, Attorney-in-Fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.